Continuous treatment with morphine increases diazepam binding inhibitor mRNA in mouse brain

Journal of Neurochemistry

Volumn 71, Issue 6, 1998, Pages 2638-2641

  Katsura, Masashi ^a   Hara, Atsuo ^a   Higo, Atsuko ^a   Tarumi, Chihaya ^a   Hibino, Yasushi ^b   Ohkuma, Seitaro ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Diazepam binding inhibitor; Morphine dependence; Morphine withdrawal; Mouse cerebral cortex; Opioid receptors

Indexed keywords

BETA ACTIN; DIAZEPAM BINDING INHIBITOR; MESSENGER RNA; MORPHINE; NALOXONE; NEUROPEPTIDE; OPIATE RECEPTOR; POLYADENYLATED RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG WITHDRAWAL; MALE; MOUSE; NARCOTIC DEPENDENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031773490     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71062638.x     Document Type: Article

References (25)

1. Alho H., Costa E., Ferrero P., Fujimoto M., Murphy D.-C., and Guidotti A. (1985) Diazepam-binding inhibitor: a neuropeptide located in selected neuronal populations of rat brain. Science 229, 179-182.
2. Amgo A., Galvan A., Heredia A., and Morales M. (1995) Naloxone blocks the antianxiety but not the motor effects of benzodiazepines and pentobarbital: experimental studies and literature review. Psychopharmacology (Berl.) 120, 186-194.
3. Bhargava H. N. (1994) Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior. Pharmacol. Rev. 46, 293-324.
4. Corda M. G., Ferrari M., Guidotti A., Konkel D., and Costa E. (1984) Isolation, purification and partial sequence of a neuropeptide (diazepam binding inhibitor) precursor of an anxiogenic putative ligand for benzodiazepine recognition sites. Neurosci. Lett. 47, 319-324.
5. Costa E. and Guidotti A. (1991) Diazepam binding inhibitor (DBI): a peptide with multiple biological actions. Life Sci. 49, 325-344.
6. Costa E., Cheney D. L., Grayson D. R., Korneyev A., Longone P., Pani L., Romeo E., Zivkovich E., and Guidotti A. (1994) Pharmacology of neurosteroid biosynthesis. Role of the mitochondrial DBI receptor (MDR) complex. Ann. NY Acad. Sci. 746, 223-242.
7. Ferrarese C., Appollonio I., Bianchi G., Frigo M., Marzorati C., Pecora N., Perego M., Pierpaoli C., and Frattola L. (1993) Benzodiazepine receptors and diazepam binding inhibitor: a possible link between stress, anxiety and the immune system. Psychoneuroendocrinology 18, 3-22.
8. Funada M., Narita M., Suzuki T., and Misawa M. (1993) Effect of pretreatment with pertussis toxin on the development of physical dependence of morphine. Naunyn Schmiedebergs Arch. Pharmacol. 348, 88-95.
9. Guidotti A., Forchetti C. M., Corda M. G., Konkel D., Bennett C. D., and Costa E. (1983) Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc. Natl. Acad. Sci. USA 80, 3531-3535.
10. Guidotti A., Ferrero P., Fujimoto M., Santi R. M., and Costa E. (1986) Studies on endogenous ligands (endocoids) for the benzodiazepine/beta-carboline binding sites. Adv. Biochem. Psychopharmacol. 41, 137-148.
11. Harris G. C. and Aston-Jones G. (1994) Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 371, 155-157.
12. Kato T. (1991) Sequence analysis of twenty mouse brain cDNA clones selected by specific expression patterns. J. Neurosci. 2, 704-711.
13. Katsura M., Ohkuma S., Tsujimura A., and Kuriyama K. (1995a) Increase of diazepam binding inhibitor mRNA levels in the brains of chronically ethanol-treated and -withdrawn mice. J. Pharmacol. Exp. Ther. 273, 1529-1533.
14. Katsura M., Ohkuma S., Xu J., Tsujimura A., and Kuriyama K. (1995b) Ethanol stimulates diazepam binding inhibitor (DBI) mRNA expression in primary cultured neurons. Brain Res. Mol. Brain Res. 34, 355-359.
15. Katsura M., Ohkuma S., Tsujimura A., Xu J., Hibino Y., Ishikawa E., and Kuriyama K. (1998) Functional involvement of benzodiazepine receptors in ethanol-induced increases of diazepam binding inhibitor (DBI) and its mRNA in the mouse brain. Brain Res. Mol. Brain Res. 54, 124-132.
16. Maldonado R., Dauge V., Callebert J., Villette J. M., Fournie-Zaluski M. C., Feger J., and Roques B. P. (1986) Comparison of selective and complete inhibitors of enkephalin-degrading enzymes on morphine withdrawal syndrome. Eur. J. Pharmacol. 165, 199-207.
17. Matthes H. W. D., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Meur L. M., Dolle P., Tzavara E., Hanoune J., Roques B. P., and Kieffer B. L. (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature 383, 819-823.
18. Mocchetti I. and Santi M. R. (1991) Diazepam binding inhibitor peptide: cloning and gene-expression. Neuropharmacology 30, 1365-1371.
19. Nestler E. J., Hope B. T., and Widnell K. L. (1993) Drug addiction: a model for the molecular basis of neural plasticity. Neuron 11, 995-1006.
20. Payeur R., Lydiard P. B., Ballenger J. C., Karaia M. T., Fossey M. D., and Zealberg J. (1992) CSF diazepam-binding inhibitor concentrations in panic disorder. Biol. Psychiatry 32, 712-716.
21. Ponte P., Ng S. Y., Engel J., Gunning F., and Kedas L. (1984) Evolutionary conservation in the untranslated regions on actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res. 12, 1687-1691.
22. Shoyab M., Gentry L. E., Marquardt H., and Todaro G. J. (1986) Isolation and characterization of a putative endogenous benzodiazepine (endozepine) from bovine and human brain. J. Biol. Chem. 261, 11968-11973.
23. Suzuki T. (1990) Pharmacological studies on drug dependence in rodents: dependence on opioids and CNS depressants. Jpn. J. Pharmacol. 52, 1-10.
24. Suzuki T., Yoshii T., and Yanaura S. (1984) Induction of physical dependence on morphine in mice by the drug-admixed food method. Jpn. J. Pharmacol. 34, 319-325.
25. Wei E., Loh H. H., and Way E. L. (1973) Quantitative aspects of precipitated abstinence in morphine dependent rats. J. Pharmacol. Exp. Ther. 184, 398-403.